A comprehensive plan for managed care of patients infected with Human Immunodeficiency Virus

被引:3
|
作者
Bartlett, JG [1 ]
Moore, R [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
关键词
D O I
10.1086/520179
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Medicaid is rapidly moving toward managed care throughout the United States and will have a major impact on care programs for those infected with human immunodeficiency virus (HIV). The experience at the Johns Hopkins HIV Care Service is an example of the transition from fee-for-service to managed care. The Maryland Medicaid program, which has required enrollment of all Medicaid recipients since June 1997, uses an adjusted payment rate and separately funds protease inhibitors. Elements that made the transition to a managed care organization possible included the early development of a comprehensive network of services and a database showing that historical Medicaid payments were low compared with the statewide experience, Our Medicaid managed care program promotes unlimited access to specialists, rejects the "gatekeeper" concept for any service, and includes an open formulary. Nevertheless, it is uncertain that the services now provided can be sustained with anticipated reductions in payments that seem inevitable with Medicaid policies here and nationally.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 50 条
  • [31] Syphilitic uveitis in patients infected with human immunodeficiency virus
    Thi, HCT
    Cassoux, N
    Bodaghi, B
    Fardeau, C
    Caumes, E
    Lehoang, P
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 243 (09) : 863 - 869
  • [32] NEUTROPENIA IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
    ISRAEL, DS
    PLAISANCE, KI
    CLINICAL PHARMACY, 1991, 10 (04): : 268 - 279
  • [33] Psoas abscess in patients infected with the human immunodeficiency virus
    López, VN
    García, FL
    Escoda, EG
    Colomé, JG
    Pérez, AM
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (08) : 661 - 663
  • [34] Cobalamin deficiency in patients infected with the human immunodeficiency virus
    Remacha, AF
    Cadafalch, J
    SEMINARS IN HEMATOLOGY, 1999, 36 (01) : 75 - 87
  • [35] Coronary risk in patients infected by human immunodeficiency virus
    Sánchez, FM
    Alonso, AV
    Castaño, IA
    Linde, FA
    REVISTA CLINICA ESPANOLA, 2004, 204 (05): : 290 - 290
  • [36] VARICELLA IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
    PERRONNE, C
    LAZANAS, M
    LEPORT, C
    SIMON, F
    SALMON, D
    DALLOT, A
    VILDE, JL
    ARCHIVES OF DERMATOLOGY, 1990, 126 (08) : 1033 - 1036
  • [37] Tuberculous meningitis in patients infected with human immunodeficiency virus
    Ravindra Kumar Garg
    Manish Kumar Sinha
    Journal of Neurology, 2011, 258 : 3 - 13
  • [38] MYALGIAS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS
    BUSKILA, D
    LANGEVITZ, P
    AMERICAN JOURNAL OF MEDICINE, 1989, 86 (04): : 510 - 511
  • [39] Microbiology of osteomyelitis patients infected with the human immunodeficiency virus
    Zalavras, CG
    Gupta, N
    Patzakis, MJ
    Holtom, PD
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2005, (439) : 97 - 100
  • [40] Syphilitic uveitis in patients infected with human immunodeficiency virus
    Thi Ha Chau Tran
    Nathalie Cassoux
    Bahram Bodaghi
    Christine Fardeau
    Eric Caumes
    Phuc Lehoang
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2005, 243 : 863 - 869